Breast Cancer

Healio spoke with Daphna Yael Spiegel, MD, MS, about screening, delays in diagnosis, and other ways the COVID-19 pandemic has impacted the breast cancer care continuum.

Black women had an increased risk for not undergoing biopsy within 90 days after abnormal screening mammography results compared with women of other racial and ethnic groups, according to study results published in JAMA Oncology.

As the number of cancer survivors in the U.S. tops 18 million, ensuring quality care for this aging population remains a challenge, according to a study published in CA: A Cancer Journal for Clinicians.

Long-term adherence to a healthy plant-based diet was associated with a 14% lower risk for breast cancer among postmenopausal women, according to findings presented at the virtual meeting of the American Society of Nutrition.

Combination therapies appeared associated with better outcomes than monotherapies for treatment of hormone receptor-positive, ERBB2-negative metastatic breast cancer, according to study results published in JAMA Network Open.

CHICAGO — Aspirin was not linked to a benefit in invasive disease-free survival, according to updated study results presented at ASCO Annual Meeting.

CHICAGO — Halle Moore, MD, director of breast medical oncology in the department of hematology and oncology at Cleveland Clinic Taussig Cancer Institute, spoke with Healio about findings from the ELAINE 2 study.

Risks for severe maternal morbidity and mortality appeared higher among pregnancies complicated by cancer, according to study results in a research letter published in JAMA Oncology.

Diagnostic mammography performance appeared to vary across racial and ethnic groups, according to study results published in Cancer Epidemiology, Biomarkers & Prevention.

In the latest installment of Residency to Retirement, wealth management experts discussed how physicians can safeguard their bond investments. It was the top story in hematology/oncology last week.